InterSystems and ImmunoPrecise Antibodies (IPA) Partner to Integrate the Vector Capability of IRIS Data Platform and LENSai for Healthcare Applications
Shots:
- InterSystems and IPA’s Subsidiary BioStrand have partnered to combine vector search with biological data for improved patient care and to address the challenge of increasing data volumes in the healthcare applications
- The partnership will combine the vector search characteristics of the InterSystems’ IRIS data platform and BioStrand's LENSai platform for AI-based healthcare and life sciences applications
- The combination creates a platform that aims to offer advantages such as precision and in-depth analysis of data, enabling drug discovery & development as well as finding mechanisms of diseases along with integration & scalability
Ref: Businesswire | Image: InterSystems
Related Newswire:- Vicore’s Almee Receives the US FDA’s Breakthrough Device Designation for Pulmonary Fibrosis
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
